New approaches to treat prostate cancer (PCA) are utilizing gene therapy and aim to correct the disease at the genetic level. Getting a gene efficiently into the target cell is the subject of much interest. We used a holmium laser for transfecting rat PCA cells with the reporter gene pEGFP. By FACS analysis and fluorescence microscopy, we could demonstrate that cellular delivery of plasmid DNA was possible with high efficiencies up to 41.3%. Therefore, transfection of PCA cells by holmium laser might offer a promising new gene transfer strategy to PCA with minimal invasiveness.
Introduction
Prostate cancer (PCA) is the most commonly diagnosed cancer in men. 1 Curative therapeutic modalities for prostate cancer include surgery, radiotherapy or hormone therapy. Novel treatments like gene therapy and immunotherapy are currently under investigation. 2 Treatment decision has to be based on whether the prostate cancer is localized or not. While surgery and brachytherapy are used successfully to treat localized cancer, hormone therapy plays a key role in control of locally advanced or metastatic PCA. Among the novel therapies, gene therapy is the most exciting and promising area for the treatment of PCA. [2] [3] [4] [5] [6] Currently, no effective curative treatment in the advanced stages of PCA exists. Therefore, gene therapy is a ray of hope for many patients, because it can be used not only in early stages but also for the treatment of advanced PCA. The prostate is ideal for gene therapy as it is easily accessible and offers unique antigens (PSA, prostate-specific membrane antigen; human glandular kallikrein 2, etc. 3 The technical advances in molecular biology, genomics, the availability of tissue specific promoters, and improvement of both viral and non-viral gene delivery systems have made this approach more realistic. Currently, a variety of PCA gene therapy strategies are under investigation. 3, 6 Viral vectors are used in majority of gene therapy trials owing to their relatively high efficiency of gene transfer. 3 The most technically simple form of gene therapy is the use of naked DNA, with low or negligible immune response. It is generally administered as a plasmid containing the gene associated with an appropriate promoter. The major limitation in translating this concept of gene therapy is the low efficiency of gene transduction and delivery to the target cells. Therefore, getting the gene into the target cell with high transfection rate is the subject of great interest. Relatively new delivery approaches like electroporation, hydrodynamics and ultrasound have been shown to enhance expression of naked plasmid DNA in a variety of tissues. Among the described methods, electroporation has been used extensively, although it is highly disruptive and causes large-scale cellular death. 7 In order to increase transfection rate and minimize negative side effects, we are investigating the use of laser for transfection in rat PCA cell lines (MatLu). Lasers were shown to be efficient for introduction of foreign DNA into cultured cells. 8 It was reported that hole upon a cultured cell perforated with a finely focused laser beam was found to repair itself within a short period of time. Palumbo et al. 9 showed that gene transfer in eukaryotic cells was possible by dye-assisted laser optoporation. They also noted that the permeability of the cell membrane is modified at the site of the beam impact. Shirahata et al. 10 observed a similar effect of gene transfer when a pulse laser irradiation was focused on a cell membrane. All the above studies show that the cells upon laser irradiation undergo a change in the permeability of the plasma membrane or form pores in the membrane at the site of contact. These changes are transient and do not appear to damage the cells extensively. Several studies reported cell transfection with either neodymium : yttrium-aluminium-garnet laser (Nd : YAG), 10 argon ion laser 9, 11 or femtosecond laser. 12 However, only low rates of gene delivery have been achieved. Preliminary studies in our laboratory confirmed that Nd : YAG laser was less effective in transfecting cells with naked plasmid DNA when compared to a Holmium : YAG laser (Ho : YAG). The Ho : YAG laser might be ideal for clinical application as it is routinely used in endourology in many centres. Aim of our studies was to investigate and optimize the gene transfection in PCA cell lines in a suspension culture in vitro using a Ho : YAG laser. These studies would provide a gateway for developing laser-induced transfection as an efficient method for gene delivery to PCA.
Materials and methods

Cell culture
Rat dorsal prostate adenocarcinoma (metastatic-anaplastic tumour metastasizing to the lungs, MatLu) cell line was obtained from the European collection of animal cell cultures (ECACC, Salisbury, UK). MatLu cells were grown in RPMI 1640 (Invitrogen Ltd, Paisley, UK) supplemented with 10% fetal calf serum (FCS, Invitrogen Ltd) 2 mM glutamine (Invitrogen Ltd) and 250 nM dexamethasone (DXMT, Sigma Aldrich, Munich, Germany). Cells were routinely cultured at a confluence of 80%, seeded in T-75 flasks (BD Biosciences Clontech, Palo Alto, USA) and incubated at 371C and 5% CO 2 .
Reporter system used for transfection studies
Plasmid pEGFP-N1 (4.7 kb, BD Biosciences Clontech, Palo Alto, USA) encodes an enhanced variant of green fluorescent protein (GFP) of the Aequorea victoria green fluorescent gene. EGFP also includes chromophore mutations that increase its fluorescence intensity. EGFP is human codon with optimized expression in mammalian systems. The pEGFP-N1 plasmid DNA was purified using the QIAGEN-tip 10000 according to the QIA Filter plasmid Giga protocol.
Transfection of cells by Ho : YAG laser
In all, 80% confluent cells were taken for the transfection studies. The cells were trypsinized using Trypsin-EDTA (0.25% Trypsin, 1 mM EDTA, Invitrogen Ltd). The cell suspension was centrifuged for 5 min at 250 g. Cells were resuspended in FCS-free RPMI medium (Invitrogen Ltd). The cells were counted using a haemocytometer with trypan blue (Gibco BRL). The final concentration of the cell suspension was adjusted to 3.5 millions per ml. A measure of 1 ml of the cell suspension was then taken in a 5 ml NUNC CryoTubet Vials (Nalge Nunc International, Unit 1a, Thorn Bus Park, Hereford, UK). A volume of 300 mg of naked plasmid pEGFP-N1 DNA was added to 1 ml of the cell suspension. The laser used was a Ho : YAG laser (Wavelight Lasertech, Starnberg, Germany). The laser energy was imparted to cells by applying energy pulses into a modified Falcon tube. Studies on transfection efficiency were carried out considering various parameters like the energy level (1000-2000 mJ), impulses (50-750) and DNA concentration (100-300 mg).
Analysis of transfected cells by flow cytometry
The mortality rate of the cells after the application of laser was determined by haemocytometer and trypan blue using a similar protocol to that of counting the cells. The laser-treated cells were cultured in a T-25 (BD Falcon) with 5 ml of the normal complete RPMI medium (10% FCS, 2 mM glutamine, 250 nM DXMT, Invitrogen Ltd) and incubated at 371C and 5% CO 2 . The cells were analysed for percentage of transfection at 24 and 48 h of incubation after treatment by FACS analysis. The cells after their incubation were observed under a fluorescence microscope to visualize the EGFP expression in the transfected cells. The fluorescence intensities of the cells were analysed using a FACScalibur (Becton-Dickinson, Palo Alto, USA). Briefly, the cells were trypsinized and washed twice with phosphate-buffered saline (PBS, Invitrogen Ltd). The cells were then resuspended in 500 ml of PBS in a FACS tube (BD Falcon) for FACS measurement. The parameters for the flow cytometric analysis were set using cell suspensions as negative control, which were not subjected to the laser treatment. Negative controls (cell suspension with naked DNA only) were used to determine the efficiency of laser in relation to naked DNA delivery. Raw data obtained from the flow cytometer by the cell quest program were interpreted by the WinMDI 2.8 software (TSRI, San Diego, USA). Lipofectaminet 2000 (Invitrogen)-based transfection was used as a positive control to determine the transfection efficiency in MAT-Lu cells. A standard lipofectamine protocol was used for this purpose.
Statistics
Statistical analysis was performed with SAS software package for windows and the use of Wilcoxon test (tapproximation) and unpaired, two-sided ANOVA with Bonferoni correction. A P-value o0.05 was considered to be significant.
Results
In this study, we investigated the influence of laser energy on gene delivery into MatLu cells. Preliminary studies that a repetition rate of 10 Hz and laser energies between 1000 and 2000 mJ revealed best results. We tested impulse rates between 50 and 500 impulses with DNA concentrations between 50 and 300 mg. Cell transfection was determined 24 or 48 h after laser application.
The transfection rates increased significantly between 50 and 500 impulses as shown in Figure 1 . After 24 h and 50 impulses, the transfection rate was 2.51% (not significant). With 200 impulses/24 h, a great improvement in transfection rate to 23.65% was observable (P ¼ 0.004). Application of 500 impulses only led to a moderate, nonsignificant further improvement of the transfection rate (24.84%). No additional increase in Gene therapy in prostate cancer S Sagi et al transfection was seen with 750 impulses. A prolonged transfection interval of 48 h significantly improved gene delivery rates to 32% with 200 impulses (P ¼ 0.028) and 41.3% at 500 impulses (P ¼ 0.009; Figure 1 ). As a consequence of the high impulses, the mortality rate also increased significantly from 28.5% at 50 impulses to 78.5% at 200 impulses (P ¼ 0.021). The survival rate was less than 10% at 500 impulses.
Another parameter influencing transfection efficiency was the laser energy level. Figure 2 shows that transfection increased dose-dependently from 1000 to 2000 mJ. While the improvement of transfection rates from 1000 compared to 1600 mJ was nonsignificant, laser energies of 2000 mJ led to highly significant increases in transfection rate (1000 mJ compared to 2000 mJ P ¼ 0.009) and were set as a standard.
The concentration of the plasmid DNA also showed a positive effect on the transfection efficiency. We obtained best results with DNA concentrations of 300 mg/ml, which showed higher transfection rates in comparison to 50, 100 or 200 mg plasmid DNA concentration.
In summary, a setting, with 10 Hz repetition rate, 2000 mJ laser energy and 200 impulses was the optimum for a good transfection efficiency in MatLu cells. For these parameter settings, the results were mostly predictable and consistent with repeated trials. A representative FACS analysis with these parameters and variable impulses from 50 to 200 is shown in Figure 3 . These results were confirmed by fluorescence microscopy of the laser-treated cells that shows high transfection rates (Figure 4) . The negative controls showed transfection efficiencies of less than 1%. Lipofectamin, used as a positive control, revealed transfection rates of 95% both after 24 and 48 h of incubation.
Discussion
The efficiency of gene transfection is crucial for the success of gene therapy. We were able to show that application of Ho : YAG laser energy enhances the efficiency gene delivery. Based on our trials, transfection efficiency in MatLu cells was dependent on several parameters: laser energy, number of impulses, DNA concentration and incubation time after laser transfection. To our knowledge, the transfection rates achieved with our setting of 41.3% are the highest reported so far for experiments with naked DNA.
However, the mortality rates of the cells also rose with the increase in impulses. This could be because of the reason that the energy at such high impulse rate can affect the Mat-Lu cells unpredictably. We performed the transfection studies in cell suspensions, which can be optimized to resemble in vivo conditions. Other studies of laser-induced gene delivery were carried out on single cells. [8] [9] [10] [11] Our results, that laser engery is capable of enhancing gene transfer as well in cell suspensions, are promising for future in vivo laser application in the prostate. James et al 14 considered that direct in vivo gene transfer to urological organs is possible by physical methods like electroporation. However, this method is limited for clinical use, as the electric energy is difficult to focus and highly disruptive. Lasers might be a better choice for the gene delivery to prostate as it is safe and easily applicable to the organ.
Our excellent gene transfection rates with the Ho : YAG laser in PCA cells underline the potential of this method for gene therapy of PCA with minimal invasiveness. Our results are promising and warrant further in vivo studies for transfection of orthotopic PCA.
